Glennie MJ - Search Results

1

The INNs and outs of antibody nonproprietary names.

Jones TD, Carter PJ, Plückthun A, Vásquez M, Holgate RG, Hötzel I, Popplewell AG, Parren PW, Enzelberger M, Rademaker HJ, Clark MR, Lowe DC, Dahiyat BI, Smith V, Lambert JM, Wu H, Reilly M, Haurum JS, Dübel S, Huston JS, Schirrmann T, Janssen RA, Steegmaier M, Gross JA, Bradbury AR, Burton DR, Dimitrov DS, Chester KA, Glennie MJ, Davies J, Walker A, Martin S, McCafferty J, Baker MP. Jones TD, et al. Among authors: glennie mj. MAbs. 2016;8(1):1-9. doi: 10.1080/19420862.2015.1114320. MAbs. 2016. PMID: 26716992 Free PMC article.

2

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas.

Teeling JL, French RR, Cragg MS, van den Brakel J, Pluyter M, Huang H, Chan C, Parren PW, Hack CE, Dechant M, Valerius T, van de Winkel JG, Glennie MJ. Teeling JL, et al. Among authors: glennie mj. Blood. 2004 Sep 15;104(6):1793-800. doi: 10.1182/blood-2004-01-0039. Epub 2004 Jun 1. Blood. 2004. PMID: 15172969 Free article.

3

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

Teeling JL, Mackus WJ, Wiegman LJ, van den Brakel JH, Beers SA, French RR, van Meerten T, Ebeling S, Vink T, Slootstra JW, Parren PW, Glennie MJ, van de Winkel JG. Teeling JL, et al. Among authors: glennie mj. J Immunol. 2006 Jul 1;177(1):362-71. doi: 10.4049/jimmunol.177.1.362. J Immunol. 2006. PMID: 16785532

4

Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody.

Bleeker WK, Munk ME, Mackus WJ, van den Brakel JH, Pluyter M, Glennie MJ, van de Winkel JG, Parren PW. Bleeker WK, et al. Among authors: glennie mj. Br J Haematol. 2008 Feb;140(3):303-12. doi: 10.1111/j.1365-2141.2007.06916.x. Epub 2007 Nov 27. Br J Haematol. 2008. PMID: 18045353 Free article.

5

A model for the solution conformation of rat IgE.

Davis KG, Glennie M, Harding SE, Burton DR. Davis KG, et al. Biochem Soc Trans. 1990 Oct;18(5):935-6. doi: 10.1042/bst0180935. Biochem Soc Trans. 1990. PMID: 2083747 No abstract available.

6

Clinical trials of antibody therapy.

Glennie MJ, Johnson PW. Glennie MJ, et al. Immunol Today. 2000 Aug;21(8):403-10. doi: 10.1016/s0167-5699(00)01669-8. Immunol Today. 2000. PMID: 10916144 Review.

7

Renaissance of cancer therapeutic antibodies.

Glennie MJ, van de Winkel JG. Glennie MJ, et al. Drug Discov Today. 2003 Jun 1;8(11):503-10. doi: 10.1016/s1359-6446(03)02714-4. Drug Discov Today. 2003. PMID: 12818520 Review.

8

Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum.

Chowdhury F, Tutt AL, Chan C, Glennie M, Johnson PW. Chowdhury F, et al. J Immunol Methods. 2010 Dec 15;363(1):1-8. doi: 10.1016/j.jim.2010.09.023. Epub 2010 Sep 24. J Immunol Methods. 2010. PMID: 20869964 Clinical Trial.

9

Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.

Williams EL, Tutt AL, Beers SA, French RR, Chan CH, Cox KL, Roghanian A, Penfold CA, Butts CL, Boross P, Verbeek JS, Cragg MS, Glennie MJ. Williams EL, et al. Among authors: glennie mj. J Immunol. 2013 Oct 15;191(8):4130-40. doi: 10.4049/jimmunol.1301430. Epub 2013 Sep 11. J Immunol. 2013. PMID: 24026082

10

Neutrophils: "neu players" in antibody therapy?

Beers SA, Glennie MJ. Beers SA, et al. Among authors: glennie mj. Blood. 2013 Oct 31;122(18):3093-4. doi: 10.1182/blood-2013-09-525451. Blood. 2013. PMID: 24178960 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page